Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Diabetes drug shows potential in treating Parkinson’s disease

Diabetes drug shows potential in treating Parkinson’s disease

7th August 2017

A commonly-used diabetes therapy has been shown to have disease-modifying potential as a treatment for Parkinson's disease.

Researchers from University College London followed 60 people with Parkinson's disease as they used either a once-weekly injection of the diabetes drug exenatide for 48 weeks, or a placebo, in addition to their regular medication.

Those who used exenatide experienced better motor function at 48 weeks when they came off the treatment, which persisted after the 12-week follow-up, while those on placebo showed a decline in their motor scores.

Of particular note was the fact that the drug demonstrated the potential to affect the course of the disease itself, rather than merely addressing the symptoms.

The study's senior author Professor Tom Foltynie of the University College London Institute of Neurology said: "This is the strongest evidence we have so far that a drug could do more than provide symptom relief for Parkinson's disease."

Further testing will now be conducted to further establish exenatide's safety and impact on Parkinson's.

With over 20 years of experience within the science market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current science roles we have available, you can search for the latest job roles, register your details, or contact the team today.ADNFCR-8000103-ID-801838689-ADNFCR

We currently have 8 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.